Skip to main content
. Author manuscript; available in PMC: 2010 Nov 1.
Published in final edited form as: Clin Cancer Res. 2009 Oct 20;15(21):6511–6518. doi: 10.1158/1078-0432.CCR-09-0565

Figure 6. Detection of anti-mesothelin antibodies in serum of patients with pancreatic adenocarcinoma.

Figure 6

Serum from 56 patients and 35 healthy controls was tested for the presence of anti-human mesothelin IgG antibodies by ELISA. Serum from only one patient and one healthy control tested positive, albeit weakly, defined as an AU ≥ 0.5 at a 1:20 diluted sample(19). BSA was added as a negative control, and validated serum from a patient with ovarian carcinoma(19) was included as a positive control.